Clinical Trial Update: A Study of Modified mRNA Vaccines in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study of modified mRNA vaccines in healthy adults sponsored by ModernaTX, Inc. has completed, evaluating vaccines targeting COVID-19, seasonal influen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Modified mRNA vaccine (unspecified formulation) (messenger RNA vaccine)

Snippet

Sponsor: ModernaTX, Inc. | Conditions: SARS-CoV-2, Seasonal Influenza | Phase 1 | Status: COMPLETED